Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 232 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-02-02 | 2023-04-14 | 183483 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | TABLET | Resolved | 2023-02-02 | 2023-03-02 | 183486 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183489 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-02-02 | 2023-02-23 | 183492 |
| APO-CEFUROXIME | 250MG | TABLET | Resolved | 2023-02-02 | 2023-02-09 | 183495 |
| APO-TRIMEBUTINE | 100MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183589 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-05-12 | 184072 |
| APO-DOXAZOSIN | 1MG | TABLET | Resolved | 2023-02-09 | 2023-03-23 | 184077 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-02-09 | 2023-02-16 | 184080 |
| APO-OLANZAPINE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-06-02 | 184083 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-09 | 2023-03-02 | 184086 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-02-09 | 2023-03-16 | 184089 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2023-02-09 | 2023-09-22 | 184092 |
| APO-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-09 | 2023-06-02 | 184097 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-09 | 2023-02-23 | 184100 |
| APO-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-09 | 2023-04-06 | 184103 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-02-09 | 2023-02-23 | 184106 |
| APO-TADALAFIL | 5MG | TABLET | Resolved | 2023-02-09 | 2023-02-23 | 184109 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2023-02-09 | 2023-04-06 | 184112 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2023-02-16 | 2023-03-23 | 185004 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | To be discontinued | 2018-09-07 | 2018-11-02 | 60423 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |